Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Metabolic Changes in HIV-1-Infected Africans: A Prospective Study

Soluble urokinase plasminogen activator receptor (suPAR) is associated with inflammation and may predict lipodystrophy and dysmetabolism in human immunodeficiency virus (HIV)-infected individuals on antiretroviral therapy. We aimed to assess firstly, whether suPAR levels are elevated in treated and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Inflammation 2012-02, Vol.35 (1), p.221-229
Hauptverfasser:	Fourie, Carla M. T., Van Rooyen, Johannes M., Kruger, Annamarie, Olsen, Michael H., Eugen-Olsen, Jesper, Schutte, Rudolph, Schutte, Aletta E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdominal Fat Adult Anti-HIV Agents - therapeutic use Antiretroviral Therapy, Highly Active Biomedical and Life Sciences Biomedicine Blood Chemical Analysis Blood Pressure Female HIV Infections - drug therapy HIV Infections - immunology HIV Infections - metabolism HIV-1 HIV-Associated Lipodystrophy Syndrome - metabolism Human immunodeficiency virus Humans Immunology Internal Medicine Male Middle Aged Pathology Pharmacology/Toxicology Prospective Studies Receptors, Urokinase Plasminogen Activator - blood Receptors, Urokinase Plasminogen Activator - metabolism Rheumatology South Africa
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!